Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma

BACKGROUND: Neoadjuvant chemotherapy and short-course radiotherapy followed by resection has been gaining recognition in the treatment of rectal cancer. Avelumab is a fully human immunoglobulin that binds Programmed Death-Ligand 1 (PD-L1) and prevents the suppression of the cytotoxic T cell immune r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Shamseddine, Ali, Zeidan, Youssef H., El Husseini, Ziad, Kreidieh, Malek, Al Darazi, Monita, Turfa, Rim, Kattan, Joseph, Khalifeh, Ibrahim, Mukherji, Deborah, Temraz, Sally, Alqasem, Kholoud, Amarin, Rula, Al Awabdeh, Tala, Deeba, Samer, Jamali, Faek, Mohamad, Issa, Elkhaldi, Mousa, Daoud, Faiez, Al Masri, Mahmoud, Dabous, Ali, Hushki, Ahmad, Jaber, Omar, Charafeddine, Maya, Geara, Fady
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542723/
https://ncbi.nlm.nih.gov/pubmed/33028346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01673-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados